Bo Zhu
Hebei Medical University(CN)Boston Children's Hospital(US)The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Harvard University(US)Army Medical University(CN)China Pharmaceutical University(CN)Yangtze University(CN)Hebei General Hospital(CN)Xinqiao Hospital(CN)Ankang City Central Hospital(CN)Qinghai Meteorological Bureau(CN)Inner Mongolia Maternal and Child Health(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Atherosclerosis and Cardiovascular Diseases, Immune cells in cancer, Ferroptosis and cancer prognosis, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification(2020)240 cited
- → Palmitoylation-dependent activation of MC1R prevents melanomagenesis(2017)236 cited
- → Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis(2019)145 cited
- → Biochar-based microbial agent reduces U and Cd accumulation in vegetables and improves rhizosphere microecology(2022)120 cited
- → Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma(2023)118 cited
- → Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy(2018)115 cited